Drupal.behaviors.print = function(context) {window.print();window.close();}>

Regulus Acquires miRNA IP from NYU

March 31, 2011

Regulus Acquires miRNA IP from NYU

The intellectual property relates to two miRNAs, miR-33a and miR-33b, as drug targets for metabolic diseases.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.

Related Stories